There are 327 Drug Development investors in the AngelBacked database, ranked below by portfolio size. The most active include David Bonita, Kristen Kosofsky and Carter Neild. Each profile lists portfolio companies, sector focus, check size, and contact details.
Head of Corporate Development and Strategy + Board Member
Executive Vice President, Head of Research and Development
Sign up to view contact details, LinkedIn profiles, and export investor data.
AngelBacked lists 327 angel investors and VCs who invest in Drug Development startups. The most active by portfolio size include David Bonita, Kristen Kosofsky, Carter Neild.
Ranked by number of portfolio companies, the most active Drug Development investors in the AngelBacked database are David Bonita, Kristen Kosofsky, Carter Neild. Each profile lists their portfolio, sector focus, and contact details.
Every Drug Development investor profile on AngelBacked includes a verified email address alongside their portfolio companies, sector focus, and firm. Paid plans unlock the contact details and CSV export.
Check sizes vary by stage: angel investors backing Drug Development startups typically write $25K–$100K, while Drug Development-focused VCs range from $500K to $5M+ for early-stage rounds. Filter the database by check size to match your raise.